Diagnostic criteria for Huntington's disease based on natural history.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1335, doi. 10.1002/mds.26011
- By:
- Publication type:
- Article
Works matching IS 08853185 AND DT 2014 AND VI 29 AND IP 11
Results: 17
1
2
Stem cells for cell replacement therapy: A therapeutic strategy for HD?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1446, doi. 10.1002/mds.26026
- By:
- Publication type:
- Article
3
Mind the gap: Models in multiple species needed for therapeutic development in Huntington's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1397, doi. 10.1002/mds.26008
- By:
- Publication type:
- Article
4
Preclinical models: Needed in translation? A Pro/Con debate.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1391, doi. 10.1002/mds.26010
- By:
- Publication type:
- Article
5
Clinical trials in Huntington's disease: Interventions in early clinical development and newer methodological approaches.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1419, doi. 10.1002/mds.26021
- By:
- Publication type:
- Article
6
Onset of Huntington's disease: Can it be purely cognitive?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1342, doi. 10.1002/mds.25997
- By:
- Publication type:
- Article
7
Current therapeutic options for Huntington's disease: Good clinical practice versus evidence-based approaches?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1404, doi. 10.1002/mds.26014
- By:
- Publication type:
- Article
8
Targets for future clinical trials in Huntington's disease: What's in the pipeline?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1434, doi. 10.1002/mds.26007
- By:
- Publication type:
- Article
9
Metabolism in HD: Still a relevant mechanism?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1366, doi. 10.1002/mds.25992
- By:
- Publication type:
- Article
10
Huntingtin-lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1455, doi. 10.1002/mds.26020
- By:
- Publication type:
- Article
11
Chorea associated with Huntington's disease: To treat or not to treat?
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1414, doi. 10.1002/mds.25996
- By:
- Publication type:
- Article
12
Magnetic resonance imaging striatal volumes: A biomarker for clinical trials in Huntington's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1429, doi. 10.1002/mds.26013
- By:
- Publication type:
- Article
13
Animal models of Huntington's disease for translation to the clinic: Best practices.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1375, doi. 10.1002/mds.26006
- By:
- Publication type:
- Article
14
Huntington's disease: A field on the move.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
15
Genetic modifiers of Huntington's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1359, doi. 10.1002/mds.26001
- By:
- Publication type:
- Article
16
Determinants of functional disability in Huntington's disease: Role of cognitive and motor dysfunction.
- Published in:
- Movement Disorders, 2014, v. 29, n. 11, p. 1351, doi. 10.1002/mds.26012
- By:
- Publication type:
- Article
17
Cover Information.
- Published in:
- 2014
- Publication type:
- Other